Login

David Richards, CEO of WANdisco PLC, recently discussed his company's approach to simplifying cloud technology.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
John B. Wood, CEO of Telos, highlights the strategic partnership with AWS as a means to enhance cybersecurity solutions through scalable cloud-based services.
00:10:00
Reflecting on an Exceptional Week of Competitive Golf and Philanthropy | Jonathan Thomas, CEO , American Century Investments.
00:10:00
Dominique Senequier Reflects: Ardian's Decade of Success and Defying Doubters | Dominique Senequier, President, Ardian.
00:10:00
Brian Jean on Alberta's Energy Future and Global Leadership
00:10:00
Atento Capital is an early-stage investment firm focused on unlocking unsung potential|Will Gray,Co-founder & Managing Partner,Atento Capital
00:10:00
The Evolving FinTech Landscape|Andrew Steele,Partner,Activant Capital
00:10:00
The International Investment Forum (IIF) offers insights on global investment trends and ideas across industries, sourced from top executives and managers worldwide.|Lindsay Dudfield Ceo of Jindalee Resources Limited
00:10:00
Diversity and Inclusion Report: US 2023 | Frank Weil - American lawyer & Founding Partner of Weil, Gotshal & Manges
00:10:00
Day one partner for developer first SaaS & crypto infrastructure founders|Ed Sim,Managing Partner,Boldstart Ventures
00:10:00
Building the Future: Larry Fink of BlackRock and Adebayo Ogunlesi of GIP Discuss $12.5 Billion Deal and the Infrastructure Revolution
00:10:00
Navigating Loss, Inheritance, and New Beginnings
00:10:00
Equity Mates provides insights into Catapult Group International Limited (ASX: CAT) with 89 views from one month ago.

© 2017 - Neuhu+